Table 3.
Individual endoscopist performance in cohort C.
| Endoscopist N per Era: 1, 2, and 3 |
Sedation administration, % (CI) | CCR, % (CI) | ADR, % (CI) | CR, % (CI) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Era 1 | Era 2 | Era 3 | Era 1 | Era 2 | Era 3 | Era 1 | Era 2 | Era 3 | Era 1 | Era 2 | Era 3 | |
| (1) N = 20,0, 0 |
80.0 (62.5–97.5) |
95 (85.4–100) |
25 (6–44) |
0 (0) |
||||||||
|
| ||||||||||||
| (2) N = 136,0, 0 |
52.0 (43.6–60.4) |
93.4 (89.2–97.6) |
23.5 (16.4–30.6) |
2,9 (0.1–5.7) |
||||||||
|
| ||||||||||||
| (3) N = 45,64,51 |
37.8 (23.6–50) |
60.9a
(51–72.9) |
72.5c
(60.2–84.8) |
91.1 (82.8–99.4) |
95.3 (90.1–100) |
100c
(100) |
31.1 (17.6–44.6) |
39.1 (27.1–51.1) |
38.0 (24.7–51.3) |
4.4 (0–10.4) |
1.6 (0–4.7) |
0.0 (0) |
|
| ||||||||||||
| (4) N = 78,115,85 |
46.2 (35.1–57.3) |
66.1a
(57.4–74.8) |
90.6b,c
(84.4–96.8) |
93.6 (88.2–99) |
99.1 (97.4–100) |
98.8 (96.5–100) |
25.6 (15.9–35.3) |
36.5 (27.7–45.3) |
42.4c
(31.9–52.9) |
1.3 (0–3.8) |
0.9 (0–2.6) |
0.0 (0) |
|
| ||||||||||||
| (5) N = 40,89,0 |
50.0 (34.5–64.0) |
71.9a
(64.6–81.2) |
92.5 (84.3–100) |
94.4 (89.6–99.2) |
30 (15.8–44.2) |
27 (17.8–36.2) |
2.5 (0–7.3) |
2.0 (0–4.9) |
||||
|
| ||||||||||||
| (6) N = 0,83,98 |
78.3 (69.4–87.2) |
94.9b
(90.5–99.3) |
96.4 (92.4–100) |
96.9 (93.5–100) |
22 (13.1–30.9) |
27.6 (18.7–36.5) |
2.4 (0–5.7) |
2.1 (0–4.9) |
||||
|
| ||||||||||||
| (7) N = 0,51,0 |
62.7 (49.4–76) |
86.4 (77–95.8) |
25.5 (13.5–37.5) |
2.5 (0–6.8) |
||||||||
N: number of colonoscopies; SAR: sedation administration rate; CI: 95% confidence interval; CCR: colonoscopy completion rate; ADR: adenoma detection rate; CR: early complications rate; asignificance over Era 1; bsignificance over Era 2; csignificance of Era 3 over Era 1.